Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Boyer

Showing results (421-430 of 428) with videos related to

Pageof 43
Sort By:
You have reached the last page of results.This site can display upto 428 results.
Ophthalmology|September 3, 2019
Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 TrialDavid S Liao, Federico V Grossi, Delphine El Mehdi, et al.
Ophthalmology|July 23, 2015
Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID StudiesDavid M Brown, Ursula Schmidt-Erfurth, Diana V Do, et al.
Lancet (London, England)|March 10, 2024
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trialDavid M Brown, David S Boyer, Diana V Do, et al.
Ophthalmology|November 12, 2025
Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: Ninety-Six-Week Results from the Randomized Phase 2/3 PHOTON TrialDiana V Do, Charles C Wykoff, Sobha Sivaprasad, et al.
Ophthalmology|July 12, 2014
Intravitreal aflibercept for diabetic macular edemaJean-François Korobelnik, Diana V Do, Ursula Schmidt-Erfurth, et al.
Journal of Internal Medicine|July 2, 2013
Improving data and knowledge management to better integrate health care and researchM Cases, L I Furlong, J Albanell, et al.
The British Journal of Ophthalmology|May 4, 2026
Expert consensus on fundus fluorescein angiography reporting in ophthalmology: a Delphi studyRoshan Karri, David C Sousa, Xavier Hadoux, et al.
Science (New York, N.Y.)|May 8, 2010
Climate change and the integrity of scienceP H Gleick, R M Adams, R M Amasino, et al.
Pageof 43

Showing results (421-430 of 428) with videos related to

Sort By:
Pageof 43
You have reached the last page of results.This site can display upto 428 results.
Ophthalmology|September 3, 2019
Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 TrialDavid S Liao, Federico V Grossi, Delphine El Mehdi, et al.
Ophthalmology|July 23, 2015
Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID StudiesDavid M Brown, Ursula Schmidt-Erfurth, Diana V Do, et al.
Lancet (London, England)|March 10, 2024
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trialDavid M Brown, David S Boyer, Diana V Do, et al.
Ophthalmology|November 12, 2025
Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: Ninety-Six-Week Results from the Randomized Phase 2/3 PHOTON TrialDiana V Do, Charles C Wykoff, Sobha Sivaprasad, et al.
Ophthalmology|July 12, 2014
Intravitreal aflibercept for diabetic macular edemaJean-François Korobelnik, Diana V Do, Ursula Schmidt-Erfurth, et al.
Journal of Internal Medicine|July 2, 2013
Improving data and knowledge management to better integrate health care and researchM Cases, L I Furlong, J Albanell, et al.
The British Journal of Ophthalmology|May 4, 2026
Expert consensus on fundus fluorescein angiography reporting in ophthalmology: a Delphi studyRoshan Karri, David C Sousa, Xavier Hadoux, et al.
Science (New York, N.Y.)|May 8, 2010
Climate change and the integrity of scienceP H Gleick, R M Adams, R M Amasino, et al.
Pageof 43